Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Terminated 2Suspended 2Recruiting 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

Magnesium 1Carnitine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Dyslipidemias × Clear all
NCT07298564 2025-12-23

Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)

Science & Research Islamic Azad University Branch Khozestan

Phase NA Recruiting
84 enrolled

Hirsutism, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Dyslipidemias

NCT04442334 2023-01-06

The European NAFLD Registry

Newcastle University

Recruiting
10,000 enrolled
GastrointestinalOther

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Hypertension, Liver Cirrhosis, Obesity, Dyslipidemias, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡